BCG Vaccine Market Segmented Analysis by Demographics and Adults | Industry Statistics 2023

The Bacillus Calmette-Gurin vaccine (BCG) is the only vaccine currently available for the prevention of tuberculosis (TB). A dose of BCG vaccine is recommended for healthy babies at birth in countries where tuberculosis is common. According to Allied Market Research the global BCG vaccine market was valued at from $20,366 thousand in 2016, and is estimated to reach $28,051 thousand by 2023, growing at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/4419?utm_source=openpr_ss

The main factor contributing to the growth of the market is the increase in the rate of incidence of tuberculosis in developing countries, the increase in R & D activities related to vaccines and the growth of government initiatives and the focus on immunization programs worldwide. However, the side reactions of BCG vaccines in patients and the shortage of vaccine supply hamper market growth. In addition, untapped market opportunities in developing regions are expected to provide numerous opportunities for market growth.

The pediatric segment is expected to maintain its dominant position during the period of analysis, since the vaccine is administered to all children at the time of birth. As BCG is recommended for a single dose; therefore, it is rarely used in the case of adults.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4419?utm_source=openpr_ss

Major Companies:

• Merck & Co. Inc.
• Sanofi Pasteur
• Japan BCG Laboratory
• Serum Institute of India Pvt. Ltd.
• InterVax Ltd.
• GreenSignal BioPharma Limited

Key Findings of the BCG Vaccine Market:

• The pediatric segment accounted for more than three quarters of the world market share in 2016.

• China is expected to grow at a rapid CAGR of 6.2% from 2017 to 2023.

• India accounted for one sixth of the global market in 2016.

• The adult segment is expected to grow at a CAGR of 3.6% from 2017 to 2023.

Browse More Information of Report @ https://www.alliedmarketresearch.com/press-release/BCG-vaccine-market.html

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.